Literature DB >> 7738165

Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.

B Arnljots1, B Dahlbäck.   

Abstract

The antithrombotic effects of bovine activated protein C (APC) and protein S were investigated in a rabbit model of microarterial thrombosis. Because of the species specificity of the APC-protein S interaction, bovine APC expresses potent anticoagulant activity in rabbit plasma only when bovine protein S is also present. This provided a way to assess the contribution of bovine protein S to the antithrombotic effect of bovine APC. Rabbits were infused with boluses of activated protein C (0.1, 0.2, 0.4, or 0.8 mg/kg), protein S (0.5 mg/kg), or activated protein C (0.1 or 0.01 mg/kg) plus protein S (0.5 mg/kg). APC alone produced a dose-dependent antithrombotic effect, but only the group receiving the highest dose differed significantly from controls. While a low dose of activated protein C (0.1 mg/kg) alone had no antithrombotic effect, together with protein S (0.5 mg/kg) it produced a potent response. The presented results demonstrate the in vivo significance of protein S as a cofactor to activated protein C. The data show that a potent antithrombotic effect, without hemorrhagic side effects or significant systemic anticoagulation, may be achieved by low doses of activated protein C when combined with protein S.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738165      PMCID: PMC295772          DOI: 10.1172/JCI117883

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.

Authors:  G Tans; J Rosing; M C Thomassen; M J Heeb; R F Zwaal; J H Griffin
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

2.  Prevention of microvascular thrombosis with low-dose tissue plasminogen activator.

Authors:  B Arnljots; J B Wieslander; P Dougan; L Salemark
Journal:  Plast Reconstr Surg       Date:  1992-08       Impact factor: 4.730

3.  Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.

Authors:  B Arnljots; D Bergqvist
Journal:  Plast Reconstr Surg       Date:  1995-04       Impact factor: 4.730

4.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

Authors:  S R Hanson; J H Griffin; L A Harker; A B Kelly; C T Esmon; A Gruber
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Anticoagulant protein C pathway defective in majority of thrombophilic patients.

Authors:  J H Griffin; B Evatt; C Wideman; J A Fernández
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

6.  Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S.

Authors:  X He; B Dahlbäck
Journal:  Eur J Biochem       Date:  1993-11-01

7.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries.

Authors:  H Araki; K Nishi; N Ishihara; K Okajima
Journal:  Thromb Res       Date:  1991-05-01       Impact factor: 3.944

9.  Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.

Authors:  M J Heeb; R M Mesters; G Tans; J Rosing; J H Griffin
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

Review 10.  Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.

Authors:  B Dahlbäck
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

View more
  5 in total

1.  Species-specific anticoagulant and mitogenic activities of murine protein S.

Authors:  José A Fernández; Mary J Heeb; Xiao Xu; Itender Singh; Berislav V Zlokovic; John H Griffin
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

2.  Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.

Authors:  William E Plautz; Vijaya Satish Sekhar Pilli; Brian C Cooley; Rima Chattopadhyay; Pamela R Westmark; Todd Getz; David Paul; Wolfgang Bergmeier; John P Sheehan; Rinku Majumder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-01       Impact factor: 8.311

3.  Modulation of protein S and growth arrest specific 6 protein signaling inhibits pancreatic cancer cell survival and proliferation.

Authors:  Vijaya S Pilli; Arani Datta; Adrianne Dorsey; Bo Liu; Rinku Majumder
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

4.  Human activated protein C variants in a rat model of arterial thrombosis.

Authors:  Karl Malm; Björn Arnljots; Björn Dahlbäck
Journal:  Thromb J       Date:  2008-10-29

5.  Protein S in preventing thrombosis.

Authors:  Doerte R Fricke; Sabyasachi Chatterjee; Rinku Majumder
Journal:  Aging (Albany NY)       Date:  2019-01-25       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.